Poorer patients find thyroid cancer at later stage: study

September 20, 2012
Poorer patients find thyroid cancer at later stage: study
Income-based health disparity needs addressing, researchers say.

(HealthDay)—Poorer people are more likely than the rich to receive a thyroid cancer diagnosis after the disease has progressed to a more advanced stage, according to a new study.

The study was scheduled for presentation Thursday at a meeting of the American Thyroid Association in Quebec City, Canada.

" is an important health indicator for a number of cancers and other diseases," the meeting's program co-chairwoman, Dr. Elizabeth Pearce, of the Boston Medical Center, said in an association news release. "These new data shed light on yet another area—the time of diagnoses—in which there is a need to close the gap on this disparity."

Using a large thyroid cancer registry in Canada, researchers led by Dr. Stan Van Umm, of the Schulich School of Medicine and Dentistry at the University of Western Ontario, analyzed information on the cancer status, sex, age and socioeconomic status of nearly 1,600 patients diagnosed with thyroid cancer between January 1998 and December 2010.

Compared to younger, richer patients, older people and those with a lower average household income were more likely to receive a thyroid after it had progressed. There is, however, a 4 percent annual decline in the odds of being diagnosed with advanced thyroid cancer in old age, which suggests the disease is being detected sooner over time, the researchers said.

The earlier cancer is diagnosed, the easier it is to treat. The U.S. estimates that more than 56,000 Americans will be diagnosed with thyroid cancer this year, and about 1,800 will die of it.

Data and conclusions presented at meetings should be considered preliminary until published in a peer-reviewed medical journal.

Explore further: Have no fear: Most cases of thyroid cancer do not affect survival

More information: The U.S. National Cancer Institute provides more information on thyroid cancer.

Related Stories

Have no fear: Most cases of thyroid cancer do not affect survival

June 11, 2012
Research presented at the Society of Nuclear Medicine's 59th Annual Meeting reveals that patients with differentiated thyroid cancer live as long as people in perfect health, unless they are in the minority and have reached ...

Thyroid cancer treatment varies by hospital, study finds

August 16, 2011
Where thyroid cancer patients go for care plays a large role in whether they receive radioactive iodine treatment, a new study from the University of Michigan Comprehensive Cancer Center finds.

Study suggests obese patients have more advanced, aggressive papillary thyroid cancer

May 21, 2012
A review of medical records of patients treated at an academic tertiary care center suggests that obese patients present to their physicians with more advanced stage and more aggressive forms of papillary thyroid cancer (PTC), ...

African-Americans with thyroid cancer fare worse than whites

June 21, 2011
African-Americans have fewer incidences of thyroid cancer but have a more advanced form of the disease once they receive a diagnosis -- and are more likely to die from it, according to a new study.

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.